Sarepta Therapeutics Inc (SRPT)

02:53 AM

Sarepta, other biotech stocks tumble as FDA appoints new CBER director - Investing.com Canada

02:53 AM

02:15 AM

Sarepta (SRPT) Sees Increased Bearish Activity Ahead of Earnings | SRPT Stock News - GuruFocus

02:15 AM

02:09 AM

US FDA names oncologist Vinay Prasad as top vaccine official - marketscreener.com

02:09 AM

03:19 AM

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World

03:19 AM

May 05, 2025

Sarepta Therapeutics (SRPT) Awaits Q1 Earnings with Mixed Projec - GuruFocus

May 05, 2025

May 05, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of HealthEquity, Inc. - GlobeNewswire Inc.

May 05, 2025

May 05, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Sarepta ... - Bluefield Daily Telegraph

May 05, 2025

May 05, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Sarepta Therapeutics, Inc. - GlobeNewswire Inc.

May 05, 2025

May 05, 2025

SRPT Investors Have Opportunity to Join Sarepta Therapeutics, Inc. Fraud Investigation with the Schall Law Firm - GuruFocus

May 05, 2025

May 05, 2025

Oligonucleotide Delivery System Market Key Players Analysis - openPR.com

May 05, 2025

May 05, 2025

Earnings To Watch: Sarepta Therapeutics (SRPT) Reports Q1 Results Tomorrow - Yahoo Finance

May 05, 2025

May 02, 2025

Ratios Revealed: Decoding Sarepta Therapeutics Inc (SRPT)’s Financial Health - DWinneX

May 02, 2025

May 02, 2025

Sarepta Therapeutics Inc [SRPT] stock for 248,203 USD was sold by Nicaise Claude - knoxdaily.com

May 02, 2025

May 01, 2025

Sarepta Therapeutics (SRPT) Reports Next Week: Wall Street Expects Earnings Growth - MSN

May 01, 2025

May 01, 2025

Duchenne Muscular Dystrophy Market Forecasted to Surge - openPR.com

May 01, 2025

Apr 30, 2025

Adversity is less terrifying than hope: Sarepta Therapeutics Inc (SRPT) - Sete News

Apr 30, 2025

Apr 29, 2025

Why Sarepta Therapeutics, Inc. (SRPT) is Among the Best Oversold NASDAQ Stocks to Buy Right Now - Yahoo Finance

Apr 29, 2025

Apr 29, 2025

11 Oversold NASDAQ Stocks to Buy Right Now - Insider Monkey

Apr 29, 2025

Apr 29, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Sarepta Therapeutics, Inc. – SRPT - TradingView

Apr 29, 2025

Apr 29, 2025

SRPT Investors Have Opportunity to Join Sarepta Therapeutics, In - GuruFocus

Apr 29, 2025

Apr 29, 2025

Sarepta Therapeutics Inc (SRPT) did well last session? - uspostnews.com

Apr 29, 2025

Apr 29, 2025

Recent Insider Activity Suggests Potential Gains for Sarepta Therapeutics Inc (SRPT) - knoxdaily.com

Apr 29, 2025

Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025

Apr 25, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta - Bluefield Daily Telegraph

Apr 25, 2025

Apr 24, 2025

Sarepta Therapeutics Inc (SRPT)’s Market Momentum: Closing Strong at 59.49, Up 0.30 - DWinneX

Apr 24, 2025

Apr 24, 2025

Cns Specific Antisense Oligonucleotide Market Generated - openPR.com

Apr 24, 2025

Apr 24, 2025

Sarepta Therapeutics (SRPT): Among Billionaire George Soros’ Small-Cap Stocks with Huge Upside Potential - MSN

Apr 24, 2025

Apr 24, 2025

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Shares Sold by Cerity Partners LLC - Defense World

Apr 24, 2025

Apr 24, 2025

How To Trade (SRPT) - news.stocktradersdaily.com

Apr 24, 2025

Apr 24, 2025

Billionaire George Soros’ 10 Small-Cap Stocks with Huge Upside Potential - Insider Monkey

Apr 24, 2025

Apr 23, 2025

Get in on Sarepta Therapeutics Inc’s (SRPT) buy-in window today! - Sete News

Apr 23, 2025

Apr 23, 2025

Why Do Investors Buy Stock In Sarepta Therapeutics Inc (SRPT)? - Marketing Sentinel

Apr 23, 2025

Apr 22, 2025

Sarepta Therapeutics Inc [SRPT] Stock sold by Insider Nicaise Claude for $0.25 million - knoxdaily.com

Apr 22, 2025

Apr 22, 2025

SRPT Quantitative Stock Analysis - Nasdaq

Apr 22, 2025

Apr 22, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc.SRPT - PR Newswire

Apr 22, 2025

Apr 22, 2025

Sarepta: Gene therapy Elevidys has given ‘hope’ to DMD community - Muscular Dystrophy News

Apr 22, 2025

Apr 22, 2025

Why Sarepta Therapeutics And Other Genetics Stocks Just Got A Sizable Boost - MSN

Apr 22, 2025

Apr 22, 2025

Sarepta Therapeutics Inc (SRPT) produces promising results - uspostnews.com

Apr 22, 2025

Apr 22, 2025

Sarepta Therapeutics to Announce First Quarter 2025 Financial Re - GuruFocus

Apr 22, 2025

Apr 22, 2025

Sarepta Therapeutics to Announce First Quarter 2025 Financial Results | SRPT Stock News - GuruFocus

Apr 22, 2025

Apr 22, 2025

Sarepta Therapeutics To Announce First Quarter 2025 Financial Results - marketscreener.com

Apr 22, 2025

Apr 22, 2025

Sarepta Therapeutics to Announce First Quarter 2025 Financial Results - Business Wire

Apr 22, 2025

Apr 22, 2025

Envestnet Asset Management Inc. Boosts Stake in Sarepta Therapeutics, Inc. (NASDAQ:SRPT) - Defense World

Apr 22, 2025

Apr 22, 2025

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Short Interest Update - Defense World

Apr 22, 2025

Apr 22, 2025

Sarepta Therapeutics (NASDAQ:SRPT) Given New $110.00 Price Target at Piper Sandler - Defense World

Apr 22, 2025

Apr 21, 2025

Is Sarepta Therapeutics, Inc. (SRPT) the Most Promising Long-Term Stock According to Analysts? - Insider Monkey

Apr 21, 2025

Apr 21, 2025

ALDX Investors Have Opportunity to Join Aldeyra Therapeutics, Inc. Fraud Investigation with the Schall Law Firm - Business Wire

Apr 21, 2025